SPONTANEOUS-ABORTION - A MEDICAL APPROACH TO MANAGEMENT

被引:16
作者
CHUNG, TKH
CHEUNG, LP
LAU, WC
HAINES, CJ
CHANG, AMZ
机构
[1] Department of Obstetrics and Gynaecology, Chinese University of Hong Kong
关键词
D O I
10.1111/j.1479-828X.1994.tb01264.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The conventional management of spontaneous abortion is surgical evacuation of the uterus to prevent complications which may arise from retained products of conception (POC). This procedure is not without complications and also demands operating theatre resources. The purpose of this study was to determine the efficacy of a medical approach to the management of spontaneous abortion using the prostaglandin analogue, gemeprost. From an initial 212 women presenting with spontaneous abortion, 4 groups were defined according to what they required in the way of initial management. A group of 20 women were excluded from conservative medical management at presentation because they were bleeding heavily and judged to be unsuitable. Sixty women initially required no further management other than determining that they had a complete abortion using transvaginal sonography (TVS). The 132 women were treated with the prostaglandin analogue, gemeprost. Sixty were judged to need no further management afterwards and were initially discharged. The remaining 72 women underwent evacuation of retained products of conception (ERPC) after the gemeprost treatment as medical evacuation of the uterus appeared to had been incomplete. In each of these 4 groups so defined, there was 1 case where an ERPC was required after the patients have been discharged because of complications attributable to retained POC. We therefore found that no ERPC was necessary in the management of 118 out of 212 (55.6%) women who presented with spontaneous abortion. This has important implications in patient management and economical use of hospital resources.
引用
收藏
页码:432 / 436
页数:5
相关论文
共 12 条
[1]  
Norman JE, Thong KJ, Rodger MW, Baird DT., Medical abortion in women of less than 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost, Br J Obstet Gynaecol, 99, pp. 601-606, (1992)
[2]  
Asch RH, Weckstein LN, Balmaceda JP, Rojas F, Spitz IM, Tadir Y., Non surgical expulsion of non‐viable early pregnancy: a new application of RU486, Hum Reprod, 5, pp. 481-483, (1990)
[3]  
Rulin MC, Bornstein SG, Campbell JD., The reliability of ultrasonography in the management of spontaneous abortion, clinically thought to be complete: A prospective study, Am J Obstet Gynecol, 168, pp. 12-15, (1993)
[4]  
Haines CJ, Chung T, Leung DYL., (1993)
[5]  
Munday D, Francome C, Savage W., Twenty one years of legal abortion, BMJ, 298, pp. 1231-1234, (1989)
[6]  
Shepherd JM, Benny JS., Septic abortion in Wellington 1960–1979, NZ Med J, 97, pp. 322-324, (1984)
[7]  
Barns AB, Ulfelder H., Sceptic abortion, JAMA, 189, pp. 919-923, (1964)
[8]  
The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy, Br J Obstet Gynaecol, 97, pp. 480-486, (1990)
[9]  
Edmund DK., Spontaneous and recurrent abortion in Gynaecology, pp. 205-218, (1992)
[10]  
Report on Confidential Enquiries into Maternal Deaths in England and Wales